ClosedPublished 2 Dec 2024

H. Lundbeck A/S /
Longboard Pharmaceuticals, Inc.

H. Lundbeck A/S completes acquisition of Longboard Pharmaceuticals, Inc.

Buy side: H. Lundbeck A/S
Buy sideH. Lundbeck A/S
Target: Longboard Pharmaceuticals, Inc.
TargetLongboard Pharmaceuticals, Inc.
Source · 2 Dec 2024Source-verified
Buy side: H. Lundbeck A/S
Buy sideH. Lundbeck A/S
Target: Longboard Pharmaceuticals, Inc.
TargetLongboard Pharmaceuticals, Inc.
01 / BuyerH. Lundbeck A/S
02 / TargetLongboard Pharmaceuticals, Inc.
Source-verified
01

What happened

H. Lundbeck A/S completed its acquisition of Longboard Pharmaceuticals, Inc. on Dec. 2, 2024. The deal followed a cash tender offer at $60.00 per Share.

Longboard Pharmaceuticals, Inc. became an indirect wholly owned subsidiary of H. Lundbeck A/S.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

H. Lundbeck A/S completes acquisition of Longboard Pharmaceuticals, Inc.

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.